NAD+

How It Works

The biology, explained.

Every second, your cells carry out countless chemical reactions.

Some build molecules.

Some break them down.

Some help release energy from food.

And some help cells respond to damage or stress.

NAD+ participates in several of these essential processes.

The NAD+ and NADH partnership

NAD+ and NADH are two forms of the same molecular system.

Think of them as a rechargeable carrier.

NAD+ can accept electrons during metabolic reactions.

When it receives them, it becomes NADH.

NADH can then deliver those electrons to other parts of cellular metabolism, including processes associated with mitochondrial energy production.

This back-and-forth is part of how cells extract usable energy from nutrients.

But NAD+ itself isn't a packet of energy like ATP.

It's a helper that makes energy-related chemistry possible.

Wait—NAD+ is involved in DNA repair?

Yes, and this is where things become especially interesting.

Your DNA is regularly exposed to damage from normal metabolism and environmental factors.

Cells contain sophisticated systems for detecting and responding to that damage.

Some proteins involved in these responses belong to a family called PARPs.

PARPs use NAD+ as a chemical substrate during cellular signaling related to DNA-damage responses.

So NAD+ isn't literally a repair crew that travels around fixing DNA.

It's a molecule that certain repair-related enzymes need to function.

The sirtuin connection

Another family of enzymes called sirtuins also uses NAD+.

Sirtuins participate in processes involving metabolism, stress responses, and protein regulation.

Experiments involving sirtuins have helped fuel interest in NAD+ and longevity.

Some animal studies suggest that manipulating these systems can influence particular aging-related processes.

But increasing NAD+ availability doesn't guarantee that every sirtuin becomes more active or that humans live longer.

Biology is more complicated than one switch.

Does NAD+ decline with age?

Researchers have observed age-related changes in NAD-related metabolism in certain tissues and populations.

But not all tissues behave identically.

And newer human studies challenge the idea that whole-blood NAD+ inevitably declines in every healthy person as they age.

The more accurate explanation is that NAD+ metabolism changes with age in ways that depend on tissue, health status, and measurement method.

How does your body make it?

Your body can build or replenish NAD+ through several pathways.

Some use nutrients derived from vitamin B3.

Others recycle NAD-related breakdown products.

Important precursors include:

• Nicotinic acid, commonly called niacin.
• Nicotinamide, another form of vitamin B3.
• Nicotinamide riboside, or NR.
• Nicotinamide mononucleotide, or NMN.

These are not all the same molecule.

NAD+ versus NR and NMN

Here's a key distinction.

NR and NMN are precursors. They participate in pathways that can produce NAD+.

NAD+ is the coenzyme itself.

Research demonstrating that oral NR increases NAD-related metabolites doesn't automatically prove that injecting NAD+ produces the same cellular effects.

And increasing a laboratory measurement doesn't guarantee improved health.

What about intravenous NAD+?

An intravenous infusion delivers NAD+ into the bloodstream.

That sounds like a direct shortcut.

But there's a catch.

Extracellular NAD+ can be broken down or chemically transformed before it reaches particular cells.

Scientists are still investigating how much administered intact NAD+ reaches different tissues, how it's metabolized, and which downstream products contribute to its effects.

Putting something into the bloodstream isn't the same as delivering it intact into every mitochondrion.

Go deeper: The science

NAD+ is a dinucleotide composed of two nucleotide units connected through phosphate groups.

It serves as a redox cofactor in metabolism and as a substrate for enzymes including PARPs, sirtuins, and NAD-consuming signaling proteins.

Its cellular abundance is regulated by synthesis, salvage, consumption, transport, and compartment-specific metabolism.

NAD+ concentrations differ among cellular compartments.

Plasma, whole-blood, and tissue measurements therefore cannot be assumed interchangeable.

The Evidence

What do the studies actually show?

NAD+ has an enormous scientific literature.

But we need to separate two very different questions.

Question one: Is NAD+ essential for normal cellular function?

Absolutely.

Question two: Does administering extra NAD+ improve health or slow aging?

That's still being investigated.

A fascinating 2019 infusion experiment

Researchers studied direct intravenous NAD+ administration in a small pilot involving 11 people.

Eight participants received NAD+ and three received saline.

The researchers measured NAD+ and related metabolites in blood and urine.

During the six-hour infusion, plasma NAD+ increased substantially, with an approximately 398% rise at the end of infusion relative to baseline.

That's a measurable pharmacological effect.

But the study primarily investigated how administered NAD+ and its metabolites behaved.

It did not demonstrate improved energy, cognition, longevity, or physical performance.

A 2026 comparison of NAD+ and NR infusions

Researchers retrospectively examined records from 14 people receiving commercial intravenous treatments.

Six received NAD+ and eight received NR.

An interesting difference emerged.

The NAD+ group reported symptoms including abdominal discomfort, nausea, increased heart rate, and chest pressure.

These symptoms resolved after infusion in the reported cases.

The study was small, retrospective, nonrandomized, and conducted in a commercial treatment setting.

It was a useful tolerability investigation—not evidence that NR or NAD+ improves longevity.

What does the broader human literature say?

A 2026 systematic review examined 113 eligible NAD-related intervention studies:

Of the 33 human studies, 28 were randomized and five were nonrandomized.

But most human supplementation research involved NAD+ precursors such as NR or NMN.

The reviewers found that these interventions could change NAD-related biomarkers.

However, improvements in functional, metabolic, or other meaningful clinical outcomes were inconsistent.

The review did not find eligible outcomes trials establishing IV or intramuscular NAD+ as an effective anti-aging or wellness intervention.

A nuance: Disease-specific research

Some researchers have also investigated NAD+ in particular medical conditions.

For example, a randomized study published in 2025 examined intravenous NAD+ in patients with heart failure due to ischemic cardiomyopathy.

That is a different research question from whether otherwise healthy adults benefit from wellness infusions.

Small disease-specific trials should be evaluated on their own methods and outcomes rather than being used as proof of generalized rejuvenation.

Can NAD+ supplementation reverse aging?

We don't have convincing human clinical evidence demonstrating that it:

• Extends lifespan.
• Reverses biological age.
• Prevents dementia.
• Restores youthful mitochondrial function throughout the body.
• Reliably improves energy in healthy adults.
• Repairs DNA damage as a demonstrated clinical outcome.
• Prevents age-related disease.

Why does the research remain exciting?

Because NAD+ biology is genuinely central to cellular function.

Researchers are studying how its availability changes during disease, how cells maintain NAD+ pools, and whether manipulating particular pathways could have clinical benefits.

Even if wellness infusions never become useful, some NAD-related interventions could still prove valuable for specific conditions.

The takeaway

We know NAD+ is essential. We know its metabolism can be manipulated. We have not established that routine NAD+ injections or infusions slow human aging.

Risks & Effects

What should people know?

NAD+ exists naturally in your body.

But naturally occurring doesn't automatically mean every concentration, formulation, or administration route is safe.

Infusion-related reactions

Human reports and clinical observations describe:

• Nausea
• Abdominal cramping
• Chest pressure
• Increased heart rate
• Flushing or warmth
• Headache
• Fatigue
• General discomfort

The severity varies.

A 2026 retrospective study found substantial infusion discomfort among all six participants receiving NAD+.

That doesn't establish how frequently these symptoms occur in the general population, but it is a concrete safety and tolerability finding.

Chest pain, breathing difficulty, or fainting should not be dismissed as ordinary treatment sensations.

An important FDA warning

In 2024, the FDA warned about the use of food-grade NAD+ ingredients in sterile compounded injectable products.

Food-grade ingredients are not automatically suitable for intravenous or other sterile administration.

The agency had received reports including severe chills, shaking, vomiting, and fatigue, sometimes requiring medical treatment.

Some were consistent with possible endotoxin contamination.

This is a different concern from NAD+'s biological activity.

Even a chemically familiar molecule can cause serious harm if an injectable preparation is contaminated.

What about subcutaneous NAD+?

Subcutaneous administration is discussed in online communities, but it has far less controlled human research than the already limited intravenous literature.

We cannot assume that IV findings establish subcutaneous safety, absorption, or clinical benefits.

Is it safe for long-term use?

Long-term safety for repeated wellness injections or infusions hasn't been adequately established.

There's also insufficient evidence to define an optimal administration regimen for improving healthspan.

What about cancer and cell growth?

NAD+ participates in pathways involving cell survival, stress responses, DNA repair, and metabolism.

Those pathways are relevant to both healthy tissues and certain diseases.

Scientists have investigated NAD-related metabolism in cancer research.

But it would be inaccurate to claim that NAD+ supplementation has been proven to cause or prevent cancer in humans.

The clinical implications depend on the disease and intervention being studied.

Regulatory status

NAD+ is an endogenous coenzyme, not an FDA-approved anti-aging medication.

Compounded injectable products are not the same as FDA-approved drug products.

Bottom line

The biological importance of NAD+ is unquestionable. The safety and usefulness of wellness injections remain much less certain.

Real Experiences

What are people saying?

NAD+ has become a major topic in longevity, wellness-clinic, and biohacking communities.

People often try it hoping for better energy, mental clarity, recovery, or general well-being.

The reported experiences are remarkably varied.

The good

Some people describe feeling more energetic or mentally clear after an infusion.

One public account described improved energy and reduced perceived pain following an NAD+ infusion accompanied by hydration fluids and glutathione.

But using multiple interventions makes it difficult to determine what caused the reported improvement.

The uncomfortable

Many people describe nausea, abdominal pressure, headaches, or an intense sense of discomfort during infusions.

Some say the sensations disappear once the treatment ends.

Interestingly, that general pattern overlaps with symptoms documented in small clinical tolerability studies.

The strange body sensations

Some users describe feeling lightheaded, flushed, or unusually aware of their heartbeat.

Others report an odd combination of tiredness and restlessness.

People have sometimes given these sensations informal nicknames, but those names shouldn't be mistaken for validated medical syndromes.

The frustrating

Some people report little noticeable improvement despite significant expense.

Others say the effects seem temporary or difficult to distinguish from better hydration, rest, or expectations.

The route question

People often debate whether oral precursors, intravenous infusions, or subcutaneous products offer the greatest benefits.

But personal impressions cannot establish which route produces the best clinical outcome.

The required comparative trials remain limited.

So what should we believe?

The experiences are useful for understanding why people seek NAD+ interventions and what they actually encounter.

But feeling energized after an infusion isn't proof that mitochondria became younger.

And feeling uncomfortable isn't evidence that cellular repair is happening.

NAD+ is a fundamental molecule of life. Whether giving people more of it improves their lives is the experiment we still need to finish.

These themes are drawn from genuine public discussions. The accounts are unverified and do not establish causation, treatment effectiveness, or population-level adverse-event frequencies.